National Trends of Antimicrobial Resistance in Uncomplicated Cystitis
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Acute uncomplicated cystitis is a common bacterial infection of the urinary bladder in women. Antibiotic resistance against Escherichia coli is increasing nationwide in Korea; therefore, we reviewed the local available data regarding acute cystitis. The recently determined susceptibilities of E. coli to gentamicin, fluoroquinolone, 3rd generation cephalosporin, and amikacin are 75%, 85-95%, 95%, and 97%, respectively. The resistance rates of E. coli to trimethoprim/sulfamethoxazole, fluoroquinolone, and even 3rd generation cephalosporin are higher in Korea compared with other countries, however, the studies that determined those resistance rates included data collected at tertiary referral hospitals, which may have been overestimated. Continuous monitoring of antibiotic resistance and opportune establishment and revision of treatment guidelines are required for the optimal management of acute cystitis.
Abstract
Acute uncomplicated cystitis is a common bacterial infection of the urinary bladder in women. Antibiotic resistance against Escherichia coli is increasing nationwide in Korea; therefore, we reviewed the local available data regarding acute cystitis. The recently determined susceptibilities of E. coli to gentamicin, fluoroquinolone, 3rd generation cephalosporin, and amikacin are 75%, 85-95%, 95%, and 97%, respectively. The resistance rates of E. coli to trimethoprim/sulfamethoxazole, fluoroquinolone, and even 3rd generation cephalosporin are higher in Korea compared with other countries, however, the studies that determined those resistance rates included data collected at tertiary referral hospitals, which may have been overestimated. Continuous monitoring of antibiotic resistance and opportune establishment and revision of treatment guidelines are required for the optimal management of acute cystitis.
참고문헌 (26)
- Hooton TM, "Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection", Int J Antimicrob Agents, 22(Suppl 2), pp.65~72 (2003)
- Fihn SD, "Clinical practice. Acute uncomplicated urinary tract infection in women", N Engl J Med, 349, pp.259~266 (2003)
- Foxman B, "Urinary tract infection: self-reported incidence and associated costs", Ann Epidemiol, 10, pp.509~515 (2000)
- Car J, "Urinary tract infections in women : diagnosis and management in primary care", BMJ, 332, pp.94~97 (2006)
- Lee SJ, "Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System", J Infect Chemother, 17, pp.440~446 (2011)
- Shin J, "Fluoroquinolone resistance in uncomplicated acute pyelonephritis:epidemiology and clinical impact", Microb Drug Resist, 18, pp.169~175 (2012)
- Lee SJ, "Antimicrobial susceptibility of uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2002", Int J Antimicrob Agents, 24(Suppl 1), pp.S61~S64 (2004)
- Wie SH, "Antibiotic sensitivity of the causative organisms and use of antibiotics in women with community-acquired acute pyelonephritis", Korean J Infect Dis, 34, pp.353~359 (2002)
- Kim SW, "Antibiotic sensitivity to the causative organism of acute simple urinary tract infection for recent 3 years", Korean J Infect Dis, 32, pp.380~387 (2000)
- Min HJ, "Acute pyelonephritis: clinical study and consideration about inpatient therapy", Korean J Med, 55, pp.232~244 (1998)
- Gupta K, "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases", Clin Infect Dis, 52, pp.e103~e120 (2011)
- Kim ME, "Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006", Int J Antimicrob Agents, 31(Suppl 1), pp.S15~S18 (2008)
- Yu Y, "Epidemiological and antibiotic resistant study on extended-spectrum beta-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in Zhejiang Province", Chin Med J (Engl), 115, pp.1479~1482 (2002)
- Johnson L, "Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates", Am J Med, 121, pp.876~884 (2008)
- Kahlmeter G., "The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report", J Antimicrob Chemother, 46(Suppl 1), pp.15~22 (2000)
- Baudry-Simner PJ, "Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals", Can J Infect Dis Med Microbiol, 23, pp.e60~e64 (2012)
- Hawkey PM, "The changing epidemiology of resistance", J Antimicrob Chemother, 64(Suppl 1), pp.i3~i10 (2009)
- Stamey TA, "Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections", N Engl J Med, 291, pp.1159~1163 (1974)
- Masterton RG, "High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women", J Antimicrob Chemother, 35, pp.129~137 (1995)
- McCarty JM, "A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim", sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group, 1999, pp.106, 292~299
- Fang GD, "Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study", Antimicrob Agents Chemother, 35, pp.1849~1855 (1991)
- Lee SE, "A clinical study of oral fosfomycin (fosmycin) in the treatment of lower urinary tract infection", Korean J Urol, 25, pp.167~172 (1984)
- 김경영, "최근 2년간 전라남도 및 광주지역의 지역사회 획득성 요로감염에 이환된 여성 환자에서 동정된 Escherichia coli의 Ciprofloxacin 내성패턴", Investigative and Clinical Urology, 49(6), pp.540~548 (2008), 대한비뇨기과학회
- 유광호, "최근 요로감염증의 주요 원인균과 항생제 감수성에 관한 고찰", Investigative and Clinical Urology, 48(6), pp.638~645 (2007), 대한비뇨기과학회
- Lee YW, "Clinical efficacy of pivmecillinam (Selexid(R))in lower urinary tract infections", Korean J Urol, 24, pp.413~417 (1983)
- 대한감염학회, "요로 감염 임상진료지침 권고안: 무증상 세균뇨, 단순 요로감염, 복잡성 요로감염, 세균성 전립선염", Infection and Chemotherapy, 43(1), pp.1~25 (2011), 대한감염학회